Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 35OTHER_GOV 3INDUSTRY 3UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 42Esophageal Neoplasms 24Stomach Neoplasms 21Rectal Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Colorectal Neoplasms 12Neoplasms 10Brain Neoplasms 10Triple Negative Breast Neoplasms 9Lung Neoplasms 9Small Cell Lung Carcinoma 8Squamous Cell Carcinoma of Head and Neck 7Neoplasm Metastasis 6Esophageal Squamous Cell Carcinoma 6Lymphoma, Large B-Cell, Diffuse 5Carcinoma, Hepatocellular 5Recurrence 4Radiation Injuries 4Nasopharyngeal Carcinoma 4Melanoma 4Lymphoma, Extranodal NK-T-Cell 4Head and Neck Neoplasms 4Uterine Cervical Neoplasms 3Meningeal Carcinomatosis 3Lymphoma 3Leukemia, Myeloid, Acute 3Hormone Receptor Positive Advanced Breast Cancer 3HER2-positive Breast Cancer 3Colonic Neoplasms 3Vomiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Gastric Adenocarcinoma × Clear all
NCT02512380 2015-08-10

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

ChineseAMS

Phase 3 Unknown
380 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡